Genprex develops gene therapies for patients with cancer and diabetes, aimed at providing new treatment options for those with limited alternatives.

Genprex

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.

COM:GENPREX

Genprex

Last Close

1.69

08/11 21:00

Market Cap

3.88M

Beta: -

Volume Today

561.88K

Avg: -

Filings Not Available